Deepinder Goyal’s wearable startup Temple acquires London-based Longevous
As part of the acquisition, Longevous founders Dr Robert Mohr and Dr Avi Roy, along with their team, will join Temple full-time.
Temple, a wearable startup backed by Deepinder Goyal, has acquired London-based Longevous, a company focused on evidence-based longevity medicine. The acquisition was announced by Goyal on X on Thursday. As part of the deal, Longevous founders Dr Robert Mohr and Dr Avi Roy, along with their respective teams, will join Temple on a full-time basis.
Mohr has been appointed Chief Medical Officer at Temple, bringing with him nearly two decades of clinical experience in emergency medicine. Roy, on the other hand, will serve as Head of Science at Temple, hailing from an Oxford-trained biomedical background. Both Mohr and Roy had been working with Temple's science team to validate its Entropy technology and the data it collects, as well as reviewing and submitting the company's first scientific manuscripts.
Longevous will continue to operate as part of Temple, while Mohr and Roy will personally manage its existing client base. Temple, founded by Goyal in 2024, is currently in the process of preparing for its launch, with plans to develop wearable technology capable of tracking physiological and health signals, while simultaneously building an in-house science team dedicated to longevity research.
Written by urgent.news from YourStory's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
